Neuropace, Inc. Common Stock (NPCE) Stock Price

NPCEStock

$12.24+15.04%52W

Market Cap$420.13M

P/E—

PEG Ratio—

Div yield—

Beta1.96

NPCE Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-30.17%

Price vs S&P 500 (4W)-14.49%

VGM Score41.92

Book Value / Share (Quarterly)$0.35

P/TBV (Annual)6.79x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)29.99%

Cash Flow / Share (Quarterly)$-0.34

Price vs S&P 500 (YTD)-32.65%

Gross Margin (TTM)79.63%

Net Profit Margin (TTM)-19.34%

EPS (TTM)$-0.57

10-Day Avg Trading Volume0.10M

EPS Excl Extra (TTM)$-0.57

Revenue Growth (5Y)19.44%

EPS (Annual)$-0.66

ROI (Annual)-27.55%

Gross Margin (Annual)77.23%

Net Profit Margin (5Y Avg)-57.82%

Cash / Share (Quarterly)$1.51

Revenue Growth QoQ (YoY)-2.95%

ROA (Last FY)-20.33%

Revenue Growth TTM (YoY)11.59%

EBITD / Share (TTM)$-0.44

ROE (5Y Avg)-159.09%

Operating Margin (TTM)-15.26%

Cash Flow / Share (Annual)$-0.34

P/B Ratio35.36x

P/B Ratio (Quarterly)45.59x

Net Income / Employee (Annual)$-102,700

EV / Revenue (TTM)4.72x

Net Interest Coverage (TTM)-3.83x

ROA (TTM)-18.71%

EPS Incl Extra (Annual)$-0.66

Current Ratio (Annual)5.28x

Quick Ratio (Quarterly)3.82x

3-Month Avg Trading Volume0.17M

52-Week Price Return15.04%

Revenue / Employee (TTM)$472,900

Tangible BV / Share (Quarterly)$0.62

P/S Ratio (Annual)4.20x

Asset Turnover (Annual)0.95x

52-Week High$19.60

Operating Margin (5Y Avg)-45.53%

EPS Excl Extra (Annual)$-0.66

CapEx CAGR (5Y)40.80%

26-Week Price Return-20.26%

Quick Ratio (Annual)4.25x

13-Week Price Return-23.88%

Total Debt / Equity (Annual)3.09x

Current Ratio (Quarterly)4.94x

Enterprise Value$466.61M

Revenue / Share Growth (5Y)11.44%

Asset Turnover (TTM)0.97x

Revenue / Employee (Annual)$478,400

Inventory Turnover (Annual)1.50x

Pretax Margin (Annual)-21.47%

Cash / Share (Annual)$1.82

3-Month Return Std Dev48.39%

Gross Margin (5Y Avg)74.03%

Net Income / Employee (TTM)$-91,500

ROE (Last FY)-112.79%

Net Interest Coverage (Annual)-3.76x

EPS Basic Excl Extra (Annual)$-0.66

Receivables Turnover (TTM)6.94x

Total Debt / Equity (Quarterly)4.97x

EPS Incl Extra (TTM)$-0.57

Receivables Turnover (Annual)7.26x

ROI (TTM)-25.52%

P/S Ratio (TTM)4.25x

Pretax Margin (5Y Avg)-57.82%

Revenue / Share (Annual)$3.06

Tangible BV / Share (Annual)$1.39

Price vs S&P 500 (52W)-0.49%

Year-to-Date Return-20.73%

5-Day Price Return-5.85%

EPS Normalized (Annual)$-0.66

ROA (5Y Avg)-29.58%

Net Profit Margin (Annual)-21.47%

Month-to-Date Return-11.05%

Cash Flow / Share (TTM)$-1.49

EBITD / Share (Annual)$-0.51

Operating Margin (Annual)-16.84%

LT Debt / Equity (Annual)3.09x

ROI (5Y Avg)-38.63%

LT Debt / Equity (Quarterly)4.97x

EPS Basic Excl Extra (TTM)$-0.57

P/TBV (Quarterly)14.44x

P/B Ratio (Annual)27.02x

Inventory Turnover (TTM)1.17x

Pretax Margin (TTM)-19.34%

Book Value / Share (Annual)$0.57

Price vs S&P 500 (13W)-26.57%

Beta1.96x

Revenue / Share (TTM)$2.90

ROE (TTM)-119.68%

52-Week Low$9.22

vGradeD

gGradeC

mGradeC

vgmGradeC

NPCE Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 11, 2026	-$0.19	-$0.18	+5.58%(+$0.01)
Q4 2025	Mar 3, 2026	-$0.15	-$0.08	+48.11%(+$0.07)
Q3 2025	Nov 4, 2025	-$0.19	-$0.11	+43.55%(+$0.08)
Q2 2025	Aug 12, 2025	-$0.22	-$0.26	-19.76%(-$0.04)

NPCE Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.21

4.20

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About Neuropace, Inc. Common Stock

NeuroPace develops implantable neuromodulation systems to treat epilepsy through its RNS System, which continuously monitors brain electrical activity and delivers personalized seizure prevention therapy. The company's comprehensive platform integrates implantable devices, clinical monitoring software, and patient management tools that support ongoing treatment outcomes. NeuroPace generates revenue from device sales, implantation procedures, and subscription-based patient management services.